The year is 1966: Lyndon B. Johnson
is the president squaring off against the Soviet Union, the Beatles are at the
height of their popularity, and Neil Armstrong is training to one day become
the first man on the moon. And, tucked
away in a laboratory at the Children’s Asthma Research Institute and Hospital
in Denver, Colorado, Kimishige Ishizaka and his team are busy at work isolating
the antibody that mediates allergic reactions, now called immunoglobulin E.
In this month’s issue of the
Journal of Allergy and Clinical Immunology, Dr. Ishizaka recounts the way in
which he and his team members eventually discovered reagin, later to be called
Immunoglobulin E (J Allergy Clin Immunol 2016; 137(6): 1646-1650). Through complex
purification techniques and shrewd application of scientific principles on
patients with plasma cell myeloma, he was able to identify the protein that led
to a local reaction to ragweed, and figured out that the binding of allergens,
like ragweed, dust mites and egg, to IgE on basophils and mast cells leads to
histamine release. Even though technology
has advanced considerably and certain practices, like Dr. Ishizaka’s use of
himself as a test subject, have changed, the role of Immunoglobulin E remains
central to the field of allergy.
No comments:
Post a Comment